EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Timing of Aortic Valve Intervention in the Management of Aortic Stenosis

Annette Maznyczka, Bernard Prendergast, Marc Dweck, Stephan Windecker, Philippe Généreux, David Hildick-Smith, Jeroen Bax, Thomas Pilgrim

JACC: Cardiovascular Interventions · 2024

DOI: 10.1016/j.jcin.2024.08.046 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JACC: Cardiovascular Interventions, 2024. Verfasst von Annette Maznyczka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: https://twitter.com/AMazn…. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Heart Valve Prosthesis Implantation, Aortic Valve, Time-to-Treatment. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aortic stenosis (AS) affects about 12% of people aged ≥75 years. Accumulating evidence on the prognostic importance of cardiac damage in patients with asymptomatic and less than severe AS supports the proposition of advancing aortic valve replacement (AVR) to earlier disease stages. Potential benefits of earlier treatment, including prevention of cardiac damage progression and reduced cardiovascular hospitalizations, need to be balanced against the earlier procedural risk and subsequent lifetime management after AVR. Two small, randomized trials indicate that early surgical AVR may improve survival in patients with asymptomatic severe AS, and observational data suggest that AVR may reduce mortality even in patients with moderate AS. A clear understanding of the pathophysiology of cardiac damage secondary to AS is needed to develop strategies to select patients for earlier AVR. Noninvasive imaging can detect early cardiac damage, and indices such as fibrosis, global longitudinal strain, and myocardial work index have potential use to guide stratification of patients for earlier AVR. Ongoing randomized trials are investigating the safety and efficacy of AVR for patients with asymptomatic severe AS and those with moderate AS who have symptoms/evidence of cardiac damage. Pathophysiological considerations and accumulating evidence from clinical studies that support earlier timing of AVR for AS will need to be corroborated by the results of these trials. This review aims to evaluate the evidence for earlier AVR, discuss strategies to guide stratification of patients who may benefit from this approach, highlight the relevant ongoing randomized trials, and consider the consequences of earlier intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Valve StenosisHeart Valve Prosthesis ImplantationAortic ValveTime-to-TreatmentHumansTime FactorsTreatment OutcomeRisk FactorsClinical Decision-MakingSeverity of Illness IndexAgedPatient SelectionRisk AssessmentPredictive Value of TestsRecovery of Function

Stichwörter der Autor:innen

aortic valve replacementasymptomatic severe aortic stenosiscardiac damagemoderate aortic stenosis

Autor:innen und Institutionen

  • Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: https://twitter.com/AMaznyczka.
  • St Thomas' Hospital and Cleveland Clinic London, London, United Kingdom.
  • British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
  • Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Department of Cardiology, Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA.
  • Sussex Cardiac Centre, Royal Sussex County Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom.

Zitieren

APA

Maznyczka, A., Prendergast, B., Dweck, M., Windecker, S., Généreux, P., Hildick-Smith, D., Bax, J., & Pilgrim, T. (2024). Timing of Aortic Valve Intervention in the Management of Aortic Stenosis. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2024.08.046

Vancouver

Maznyczka A, Prendergast B, Dweck M, Windecker S, Généreux P, Hildick-Smith D, et al. Timing of Aortic Valve Intervention in the Management of Aortic Stenosis. JACC: Cardiovascular Interventions. 2024. doi:10.1016/j.jcin.2024.08.046

BibTeX
@article{Maznyczka2024,
  author = {Maznyczka, Annette and Prendergast, Bernard and Dweck, Marc and Windecker, Stephan and Généreux, Philippe and Hildick-Smith, David and Bax, Jeroen and Pilgrim, Thomas},
  title = {Timing of Aortic Valve Intervention in the Management of Aortic Stenosis},
  journal = {JACC: Cardiovascular Interventions},
  year = {2024},
  doi = {10.1016/j.jcin.2024.08.046}
}
Kostenlos starten →